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Obesity and assisted reproduction 
 
E. Haran Duran, MD1 
 
Excess body weight impacts fertility 
during both natural and assisted 
reproduction (ART) cycles. In men, the 
immediate effect is hypoandrogenism 
through decreased testosterone levels 
and an increase in peripheral 
aromatization of androgens to estrogen, 
although this does not seem to cause 
significant change in conventional 
semen parameters.1 In women, the 
impact seems to be through various 
pathways, by both animal and human 
studies. Insulin resistance (IR) typically 
accompanies obesity, leading to 
anovulation and hyperandrogenism. 
Although ovulation can be achieved via 
ART, oocyte quality is typically poor in 
these women due to IR, 
hyperandrogenism and perhaps the 
underlying inflammatory milieu 
associated with obesity.2,3 Obese 
woman’s endocrinologic environment 
may potentially lead to unfavorable 
endometrial changes that may 
participate in the increased miscarriage 
rate, in addition to the impact of poor 
oocyte quality. Exposure to such an 
environment even during early 
embryogenesis stage may lead to 
neonatal as well as life-long 
consequences in offspring of these 
women.4,5 Among those are both 
intrauterine growth restriction (IUGR) 
and macrosomia, early development of 
metabolic syndrome, insulin resistance, 
hypertension, and atherosclerotic heart 
disease. Clinical studies indicate lower 
likelihood of both clinical and ongoing 
pregnancy, as well as live birth in obese 
women.6,7 They also indicate reduced 
number of oocytes retrieved with ART, 
despite higher doses of gonadotropins 
used.8 Various problems complicate the 
pregnancy of these women, among 
which are increased risk of 
preeclampsia, gestational diabetes, and 
cesarean section.6 The impact of obesity 
on endometrium is somewhat 
debatable, since these associations 
seem to be lost when donated oocytes 
are used,7 although conflicting findings 
exist.9 Further studies are warranted not 
only to optimize ART outcome in this 
patient population, but also to prevent 
consequences in the children of obese 
women during newborn period as well 
as the rest of their lives.  
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